Table 2.
Overlapping matrix between genes showing differential expression and allele-specific expression.
A | OD | D_F | D_L | ASE_F | ASE_L | |
---|---|---|---|---|---|---|
Brain | ||||||
A | 362 | - | - | - | - | - |
OD | 0 | 5 | - | - | - | - |
D_F | 0 | 0 | 13 | - | - | - |
D_L | 0 | 0 | 0 | 115 | - | - |
ASE_F | 16 | 0 | 0 | 2 | 674 | - |
ASE_L | 15 | 0 | 0 | 1 | 0 | 736 |
Liver | ||||||
A | 549 | - | - | - | - | - |
OD | 0 | 2 | - | - | - | - |
D_F | 0 | 0 | 31 | - | - | - |
D_L | 0 | 0 | 0 | 7 | - | - |
ASE_F | 62* | 0 | 0 | 1 | 632 | - |
ASE_L | 45* | 0 | 0 | 0 | 0 | 608 |
Abbreviations: A: Additive; OD: Over-dominance; D_F: Fayoumi dominance; D_L: Leghorn dominance; ASE: allele-specific expression; ASE_F: ASE genes with Fayoumi allele expressed higher in the F1 cross; ASE_L: ASE genes with Leghorn allele expressed higher in the F1 cross; DE: differential expression; DE_F: DE genes between F and L with expression in F greater than expression in L; DE_L: DE genes between F and L with expression in L greater than expression in F. *significant (p < 0.05, χ2 test ) overlap between DE and ASE genes.